for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

ImmuPharma PLC

IMM.L

現在値

7.93GBp

変化

0.19(+2.39%)

出来高

67,310

本日のレンジ

7.52

 - 

7.98

52週レンジ

7.00

 - 

14.75

∙ 約20分前の相場を表示しています。

価格

前日終値
7.74
始値
7.98
出来高
67,310
3か月平均出来高
12.74
高値
7.98
安値
7.52
52週高値
14.75
52週安値
7.00
発行済株式数
250.22
時価総額
19.49
予想PER
--
配当利回り
--

次のエベント

Half Year 2021 ImmuPharma PLC Earnings Release

適時開示

その他

Immupharma Says CEO Dimitri Dimitriou To Step Down From The Role

Immupharma Plc Appoints Tim Franklin As COO

ImmuPharma Says H1 Diluted EPS Loss 1.69 Pence Versus 2.8 Pence Loss Year Ago

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

ImmuPharma PLCとは

ImmuPharma plc is a drug discovery and development company. The Company is focused on the development of drugs, primarily based on peptide therapeutics, to treat serious medical conditions such as autoimmune diseases. The Company has approximately five drug candidates in development, over two platform technologies and approximately 70 patents. Lupuzor is the Company's drug candidate and is a treatment for lupus, and life threatening auto immune disease. The Company's treatment for cancer, IPP-204106, has completed a Phase I/IIa study in cancer patients in France. Its compound IPP-102199 for pain relief is designed as a non-addictive replacement for morphine and other opioids, and is in pre-clinical development. Its treatment for inflammatory and allergic disorders (IPP-201007) is in early stage development. Its compound IPP-203101 is an antibiotic against methicillin-resistant staphylococcus aureus (MRSA) and other infections. The Company's research operations are in France.

業種

Business Services

連絡先

52 Grosvenor Gardens

SW1W 0AU

United Kingdom

+44.20.71524080

https://www.immupharma.co.uk/

エグゼクティブリーダーシップ

Timothy McCarthy

Non-Executive Chairman of the Board, Interim Chief Executive Officer

Timothy Gary Franklin

Chief Operating Officer, Director

Tracy Weimar

Vice President - Operations and Finance, Company Secretary

Ewa Flynn

Company Secretary

統計

4.00 mean rating - 1 analysts
Sell
Hold
Buy
Revenue (MM, GBP)

2018

0.0K

2019

0.0K

2020

0.0K
EPS (GBp)

2018

-5.190

2019

-3.990

2020

-3.430
株価売上高倍率(過去12カ月)
--
株価売上高倍率(過去12カ月)
153.88
株価純資産倍率(四半期)
2.02
株価キャッシュフロー倍率
--
総負債/総資本(四半期)
6.65
長期負債/資本(四半期)
0.00
投資利益率(過去12カ月)
-91.93
自己資本利益率(過去12カ月)
-82.07

最新ニュース

最新ニュース

金融情報はリフィニティブから。すべての情報は少なくとも20分遅れで表示されています。

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up